Interestingly, the integrin-absent pool of molecular aggregates of CD151, which presumably corresponds to the so-called integrin-free CD151 fraction, seems to have a regulatory role in cell-cell contact and tumor resistance to therapeutic agents [47,108]. This evidence concerns the gene CD151 and neoplasm.